Home > Insider Trading > Filing (0001513935-17-000010)

Filing Details

Accession Number:: 0001513935-17-000010
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-03-02 17:15:09
Reporting Period:: 2017-02-28

Filing Date:: 2017-03-02
Accepted Time:: 2017-03-02 17:15:09
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1122388	Ellie Mae Inc	ELLI	Services-Prepackaged Software (7372)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1513935	Edgar Luce	C/O Ellie Mae, Inc. 4420 Rosewood Drive, Suite 500 Pleasanton CA 94588	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2017-02-28	2,924	$93.96	50,132	No	4	S	Direct
Common Stock	Acquisiton	2017-03-01	700	$46.24	50,832	No	4	M	Direct
Common Stock	Disposition	2017-03-01	700	$95.31	50,132	No	4	S	Direct
Common Stock	Acquisiton	2017-03-01	750	$24.93	50,882	No	4	M	Direct
Common Stock	Disposition	2017-03-01	750	$95.31	50,132	No	4	S	Direct
Common Stock	Acquisiton	2017-03-01	200	$19.60	50,332	No	4	M	Direct
Common Stock	Disposition	2017-03-01	200	$95.31	50,132	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-03-01	200	$0.00	200	$19.60
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-03-01	750	$0.00	750	$24.93
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2017-03-01	700	$0.00	700	$46.24

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,900	2023-02-04	No	4	M	Direct
7,750	2024-02-05	No	4	M	Direct
9,762	2025-02-11	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to the reporting person's Rule 10b5-1 trading plan.
Reflects shares of common stock issued and sold in connection with the Compensation Committee of the Board of Directors certification on February 25, 2016 of the achievement of performance goals under the 2015 performance share awards. 25% of the total shares awarded were issued as fully vested shares on or about March 25, 2016. An additional 25% of the total shares awarded will vest on each of February 25, 2017, February 25, 2018 and February 25, 2019, subject to continuous service through such dates.
The price reported is a weighted average price. The shares were sold in multiple transactions ranging from $93.7300 to $94.23, inclusive. The reporting person undertakes to provide to Ellie Mae, Inc., any security holder of Ellie Mae, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
The exercise and sale of these stock options was completed pursuant to the Rule 10b5-1 trading plan adopted by Edgar A. Luce.
The price reported is a weighted average price. The shares were sold in multiple transactions ranging from $95.1000 to $95.6000, inclusive. The reporting person undertakes to provide to Ellie Mae, Inc., any security holder of Ellie Mae, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Includes 252 shares acquired by the Reporting Person on February 28, 2017 under the Issuer's employee stock purchase plan in a transaction exempt from the reporting requirements under Section 16(a).
Option vests with respect to 25% of the shares subject thereto on February 4, 2014, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 4, 2017.
The reported transaction is a grant of a derivative security, in which we have left column 8 blank, and have reported the exercise or conversion price of the derivative security in column 2.
Option vests with respect to 25% of the shares subject thereto on February 5, 2015, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 5, 2018.
Option vests with respect to 25% of the shares subject thereto on February 11, 2016, with 1/48th of the shares vesting monthly thereafter, such that the option will be fully vested and exercisable on February 11, 2019.